© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Lisa Astor
Articles
Tucatinib Combination Induces Positive Intracranial Responses in HER2-Positive Breast Cancer Brain Metastases
June 04, 2020
Tucatinib in combination with trastuzumab and capecitabine yielded significant intracranial responses in patients with previously treated HER2-positive metastatic breast cancer and brain metastases.